Teleflex’s MANTA Vascular Closure Device Receives Health Canada Approval for Large Bore Femoral Arterial Access Site Closure
Shots:
- The Health Canada has approved MANTA vascular closure device as the first commercially available biomechanical device for femoral arterial access site closure
- In the (SAFE MANTA IDE) clinical trial, MANTA Device achieves fast reliable biomechanical closure with rapid hemostasis & can safely and effectively close large bore arteriotomies by TAVR, PEVAR & TEVAR devices in a patients population
- Following the use of 10-20F devices or sheaths (12-25F OD) in endovascular catheterization procedures, the MANTA VCD is approved for closure of femoral artery access sites while shortening the time to hemostasis. The device can save valuable time that offers proven & reproducible results
Ref: Globenewswire | Image: Teleflex
Click here to read the full press release
Tags
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
